IPSC - Century Therapeutics, Inc.
IEX Last Trade
1.055
0.005 0.474%
Share volume: 6,357
Last Updated: Fri 27 Dec 2024 08:29:09 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$1.05
0.00
0.48%
Summary score
13%
Profitability
0%
Dept financing
12%
Liquidity
75%
Performance
10%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-12.77%
Return on assets
-7.09%
Return on sales
-9127.52%
Return on invested capital
-20.96%
Total debt ratio
39.81%
Debt ratio change over timeo
-2.99%
Current Ratio
11.9%
Quick Ratio
11.9%
Cash Position Ratio
11.66%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-16.37%
Return on assets
-8.21%
Return on sales
-16905.93%
Return on invested capital
-18.77%
Total debt ratio
45.81%
Debt ratio change over timeo
-3.23%
Current Ratio
9.82%
Quick Ratio
9.82%
Cash Position Ratio
9.52%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-15.78%
Return on assets
-8.98%
Return on sales
-3661.87%
Return on invested capital
-21.16%
Total debt ratio
48.96%
Debt ratio change over time
-3.06%
Current Ratio
12.44%
Quick Ratio
12.44%
Cash Position Ratio
11.95%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-36.53%
Return on assets
-64.64%
Return on sales
45691.01%
Return on invested capital
2.1%
Total debt ratio
-298.53%
Debt ratio change over time
-2.99%
Current Ratio
-57.81%
Quick Ratio
-57.81%
Cash Position Ratio
-56.68%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | IPSC | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -12.77% | 13.79% | 34.47% | 7.43% |
| Return on assets | -7.09% | 2.76% | 3.15% | 5.62% |
| Return on sales | -9127.52% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | -20.96% | 2.36% | 5.39% | 19.77% |
| Profitability | 0% | 43% | 66% | 80% |
| Total debt ratio | 39.81% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -2.99% | 308.97% | -6.99% | 1.18% |
| Dept financing | 11% | 50% | 25% | 7% |
| Current Ratio | 9.82% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 9.82% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 9.52% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 4% | 9% | 22% |
| Short-term ratios | IPSC | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -16.37% | 13.77% | 13.25% | 3.8% |
| Return on assets | -8.21% | 2.43% | 1.89% | 3.09% |
| Return on sales | -16905.93% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | -18.77% | 2.14% | 3.39% | 9.18% |
| Profitability | 0% | 71% | 68% | 82% |
| Total debt ratio | 45.81% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -3.23% | 46.38% | -72.08% | 1.51% |
| Dept financing | 12% | 50% | 25% | 7% |
| Current Ratio | 9.82% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 9.82% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 9.52% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 5% | 13% | 33% |